Patents by Inventor Paul L.G. SLANGEN

Paul L.G. SLANGEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200108031
    Abstract: Viability of cancer cells (e.g., glioblastoma cells) can be reduced by administering ABT-751 to the cancer cells and applying an alternating electric field with a frequency between 100 and 400 kHz (e.g., 200 kHz) to the cancer cells. Notably, experiments show that the combination of ABT-751 and the alternating electric field produces synergistic results for certain glioblastoma cell lines.
    Type: Application
    Filed: October 4, 2019
    Publication date: April 9, 2020
    Inventors: Gerben BORST, Olaf van TELLINGEN, Moshe GILADI, Mark C. de GOOIJER, Paul L.G. SLANGEN